Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
The Radix Astragali Lives The Arteries to Drink	191.73M	196.24M	205.74M	270.70M	247.94M
The Radix Astragali Lives The Arteries to Drink Growth	-2.30%	-4.62%	-24.00%	9.18%	14.83%
Shenjin Dan Capsule	22.54M	23.45M	22.93M	26.90M	28.18M
Shenjin Dan Capsule Growth	-3.85%	2.24%	-14.75%	-4.54%	3.00%
American Ginseng Oral Liquid	45.87M	40.60M	33.61M	46.70M	36.12M
American Ginseng Oral Liquid Growth	12.98%	20.81%	-28.04%	29.28%	12.56%
Other Products	4.98M	7.26M	8.01M	7.07M	8.53M
Other Products Growth	-31.31%	-9.39%	13.33%	-17.14%	12.40%
Unallocated Other Business	230.76K	117.99K	114.97K	116.52K	107.61K
Unallocated Other Business Growth	95.57%	2.63%	-1.33%	8.28%	-12.85%
Total	265.36M	267.66M	270.40M	351.49M	320.88M
Total Growth	-0.86%	-1.01%	-23.07%	9.54%	13.35%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	265.36M	267.66M	270.40M	351.49M	320.88M
China Growth	-0.86%	-1.01%	-23.07%	9.54%	13.35%
Total	265.36M	267.66M	270.40M	351.49M	320.88M
Total Growth	-0.86%	-1.01%	-23.07%	9.54%	13.35%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 1, 2026

Data Sources Report a data error